MedPath

Effects of Dry Needling Technique in Hip Muscles in Subjects With Grade I-III Hip Osteoarthritis

Not Applicable
Conditions
Hip Osteoarthritis
Interventions
Other: Sham Dry needling
Other: Dry needling
Registration Number
NCT03202056
Lead Sponsor
Universidad de Zaragoza
Brief Summary

Dry needling is a new treatment technique, addressed to mechanical pain of the neuromusculoskeletal system. Recent investigations has developed new hypothesis about the etiology of the osteoarthritis and could be in relation to musculoskeletal disorders, but there is no published studies evaluating the results of this technique in hip osteoarthritis patients.

The objective of this trial is to evaluate if dry needling is more effective in symptoms, function, range of motion, strength, muscular length, pain threshold and compared to sham dry needling and control.

For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

Patients included are randomized into 3 groups one receive Dry needling, other sham dry needling and the other is a control. Groups receive 3 treatment sessions.

The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in sham dry needling or control group, when the intervention finish the investigators will be given the opportunity to receive the actual technique.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Diagnosed medically with a X-Ray test
  • American College of Rheumatology Criteria
Exclusion Criteria
  • Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
  • Vascular or neurological disease.
  • Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
  • Grade IV in Kellgren and Laurence Scale
  • Fear of needles

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham Dry needlingSham Dry needlingSham Dry needling technique in each active myofascial trigger point once per week for 3 weeks.
Dry needlingDry needlingDry needling technique in each active myofascial trigger point once per week for 3 weeks.
Primary Outcome Measures
NameTimeMethod
Intensity symptomsthrough study completion, an average 21 days

The investigators measure the intensity of with a visual analogic scale at the end of the intervention (3 weeks after baseline the investigators measure the intensity of symptoms through study completion, an average 21 days)

Functional Capacity with functional teststhrough study completion, an average 21 days

The investigator measure the functional capacity with functional test: "Test Up and Go" (TUG test), "20 and 40 meters self-placed" and "30 seconds-chair and stand" at the end of the intervention (through study completion, an average 21 days).

Secondary Outcome Measures
NameTimeMethod
Hip Range of motionthrough study completion, an average 21 days

The investigators measure the hip range of motion with an inclinometer at the end of the intervention (through study completion, an average 21 days)

Anxiety and depression with a validated questionnaire (HADS)through study completion, an average 21 days

The investigators measure the anxiety and depression with HADS questionnaire at the end of the intervention (through study completion, an average 21 days)

Gait in treadmillthrough study completion

The investigator measure gait pattern in treadmill using wearable inertial sensors to track body kinematics during gait

Muscular strengththrough study completion, an average 21 days

The investigators measure the hip strength with a hand held dynamometer (Lafayette) at the end of the intervention (through study completion, an average 21 days)

Muscular lengththrough study completion, an average 21 days

The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at the end of the intervention (through study completion, an average 21 days)

Pain thresholdthrough study completion, an average 21 days

The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at the end of the intervention (through study completion, an average 21 days)

Functional capacity with a validated questionnaire (WOMAC)through study completion, an average 21 days

The investigator measure the functional capacity with WOMAC questionnaire at the end of the intervention (through study completion, an average 21 days)

Trial Locations

Locations (1)

Luis Ceballos Laita

🇪🇸

Zaragoza, Spain

© Copyright 2025. All Rights Reserved by MedPath